Executive Order No. 118 (2020) — —Section 3 of Republic Act (RA) No. 11494 or the—"Bayanihan—to Recover as One Act," declares it a policy of the State to sustain efforts to test, trace and treat COVID-19 cases to mitigate the transmission of the disease and prevent further loss of lives, and to reduce the adverse impact of COVID-19 on the socioeconomic well- being of all Filipinos through the provision of socioeconomic relief;

Home›Statutes›Executive Orders›Executive Order No. 118 (2020)

Executive Order No. 118 (2020)

—Section 3 of Republic Act (RA) No. 11494 or the—"Bayanihan—to Recover as One Act," declares it a policy of the State to sustain efforts to test, trace and treat COVID-19 cases to mitigate the transmission of the disease and prevent further loss of lives, and to reduce the adverse impact of COVID-19 on the socioeconomic well- being of all Filipinos through the provision of socioeconomic relief;

Jump to section

Section 1 · Price Range for COVID-19 Tests and Test Kits Section 2 · Additional Requirements for Licensing and Accreditation Section 3 · Transparency Measures Section 4 · Review and Monitoring Section 5 · Implementing Guidelines Section 6 · Separability Section 7 · Effectivity

Section 1

Price Range for COVID-19 Tests and Test Kits

Section 1.

Price Range for COVID-19 Tests and Test Kits. —The DOH, in coordination with the Department of Trade and Industry (DTI), is hereby directed to determine, formulate and implement a price range for COVID-19 testing conducted by hospitals, laboratories and other health establishments and facilities, including the test kits used in the conduct of said tests, subject to existing laws, rules and regulations.

The DOH and the DTI shall ensure that the price range for COVID-19 testing and test kits is just, equitable and sensitive to all stakeholders.

Section 2

Additional Requirements for Licensing and Accreditation

Section 2.

Additional Requirements for Licensing and Accreditation. —Compliance with the abovementioned price range shall form part of the standards and requirements for the licensing and accreditation of hospitals, laboratories and other health establishments and facilities as COVID-19 testing centers.

The DOH shall release the appropriate issuances directing all hospitals, laboratories and other health establishments and facilities with existing accreditation to operate a COVID-19 diagnostic laboratory, to observe the aforesaid price range. Failure to comply therewith may be considered as a ground for the revocation of existing licenses or accreditation.

Section 3

Transparency Measures

Section 3.

Transparency Measures. —The DOH shall institute measures to ensure that all accredited COVID-19 laboratories observe transparency in the pricing of tests, and ensure that the public is fully informed of the component costs of medical services and procedures relating to COVID-19.

Section 4

Review and Monitoring

Section 4.

Review and Monitoring. —The DOH and DTI shall undertake continuous monitoring and review of the prices and market supply of COVID-19 test kits and other basic medical items and supplies, and issue such price control measures and adjustments as may be necessary, pursuant to RA No. 7581, as amended.

Section 5

Implementing Guidelines

Section 5.

Implementing Guidelines. —The DOH, in coordination with the DTI, shall formulate and issue the necessary guidelines for the effective implementation of this Order.

Section 6

Separability

Section 6.

Separability. —If—any part or provision of this Order shall be held unconstitutional or invalid, other parts not affected thereby shall continue to be in full force and effect.

Section 7

Effectivity

Section 7.

Effectivity. —This Order shall take effect immediately upon publication in the Official Gazette or in a newspaper of general circulation.

DONE, —in the City of Manila, this 4th day of November in the Year of our Lord, Two Thousand and Twenty.

(SGD.)— RODRIGO ROA DUTERTE

By the President:

(SGD.)— SALVADOR C. MEDIALDEA Executive Secretary